Navigation Links
California Grants SeqWright License to Operate as a Clinical Laboratory
Date:3/10/2009

HOUSTON, March 10 /PRNewswire/ -- SeqWright, a world-wide leader in custom genomic and molecular biology services, announced today that it has been granted a California clinical laboratory license. This license enables SeqWright to utilize its DNA sequencing and Single Nucleotide Polymorphism (SNP) Genotyping expertise in order to provide genetic tests to California residents and represents a significant step forward in the shift towards personalized medicine. With its CLIA certification and a California clinical laboratory license, SeqWright is capable of performing validated genetic tests on individuals throughout the majority of the United States.

As personalized medicine becomes a more prominent component of modern healthcare, SeqWright stands poised to leverage its significant experience in molecular biology and genomic analysis services in order to expand its share of the market for personalized genetic tests. However, it is important to note that SeqWright generally does not develop and market such tests internally and therefore, its role would be that of a support laboratory working with industry partners on previously developed and validated assays.

On a similar note, SeqWright has recently been named as an Authorized Service Provider for NimbleGen Capture Arrays. These arrays enable whole-exome and custom-targeted enrichment of genomic DNA. The enriched genomic DNA can then be sequenced on one of SeqWright's two types of next generation genomic analysis platforms; AB SOLiD or 454 Titanium for analysis. This capability opens up the potential for a quantum leap in personalized medicine within the near future by dramatically decreasing the time and cost associated with sequencing all coding DNA (the exome) as well as custom-targeted regions within an individual's genome.

About SeqWright

Based in Houston, TX, SeqWright Incorporated is a world-class provider of genomic analysis services, including next generation sequencing. SeqWright has more than fifteen years of experience specializing in state of the art Molecular Biology and Genomic services within a highly regulated GLP/CLIA environment. For additional information about SeqWright and its services, please visit www.seqwright.com.


'/>"/>
SOURCE SeqWright Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Transgenomic Awarded Clinical Laboratory Certification in California
2. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
3. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
4. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
5. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
6. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
7. ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration
8. Phlo Affiliate Announces Significant Distribution Expansion In California
9. Californias International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
10. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
11. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):